Charles River Laboratories
CRL
HK$1,401
Share price
-0.30%
Change (1 day)
-24.64%
Change (1 year)
Categories
Charles River Laboratories (CRL) - Cash on Hand
Cash on Hand as of March 2025 : HK$1.80 Billion
According to Charles River Laboratories
's latest financial reports the company has HK$1.80 Billion in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Charles River Laboratories - Cash on Hand chart (from 2000 to 2025)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2024-12-31 | HK$1.51 B | -30.11% |
| 2023-12-31 | HK$2.16 B | 18.27% |
| 2022-12-31 | HK$1.82 B | -2.83% |
| 2021-12-31 | HK$1.88 B | 5.74% |
| 2020-12-31 | HK$1.77 B | -4.42% |
| 2019-12-31 | HK$1.86 B | 21.05% |
| 2018-12-31 | HK$1.53 B | 2.34% |
| 2017-12-31 | HK$1.50 B | 59.58% |
| 2016-12-31 | HK$0.94 B | -12.28% |
| 2015-12-31 | HK$1.07 B | -21.47% |
| 2014-12-31 | HK$1.36 B | 5.48% |
| 2013-12-31 | HK$1.29 B | 43.52% |
| 2012-12-31 | HK$0.90 B | 56.51% |
| 2011-12-31 | HK$0.57 B | -60.78% |
| 2010-12-31 | HK$1.47 B | -20.3% |
| 2009-12-31 | HK$1.84 B | -1.96% |
| 2008-12-31 | HK$1.88 B | 0.42% |
| 2007-12-31 | HK$1.87 B | 31.82% |
| 2006-12-31 | HK$1.42 B | 57.43% |
| 2005-12-31 | HK$0.90 B | -44.07% |
| 2004-12-31 | HK$1.61 B | 6.57% |
| 2003-12-31 | HK$1.51 B | 58.6% |
| 2002-12-31 | HK$0.95 B | 110.26% |
| 2001-12-31 | HK$0.45 B | 75.85% |
| 2000-12-31 | HK$0.25 B | 121.58% |
| 1999-12-31 | HK$0.11 B | -39.34% |
| 1998-12-31 | HK$0.19 B |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Repligen
RGEN | HK$5.47 B | 203.99% | 🇺🇸 USA |
 SCYNEXIS SCYX | HK$0.31 B | -82.30% | 🇺🇸 USA |
 Thermo Fisher Scientific TMO | HK$46.67 B | 2,492.91% | 🇺🇸 USA |